VRFR- Immersive Virtual Reality Use in a Spine Functional Restoration Program - A Feasibility Study
Launched by UNIVERSITY HOSPITAL, ANGERS · Dec 4, 2024
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called VRFR, is exploring the use of virtual reality (VR) technology to help people with chronic low back pain feel better and improve their movement. The main goal is to see if patients and healthcare providers find the VR headset useful and easy to use during a group rehabilitation program. Chronic low back pain affects many people and can make daily activities difficult, so this study aims to understand how VR can help in rehabilitation settings. Participants will be recruited from several healthcare centers, and they will wear a specially designed VR headset that might help reduce pain and enhance motor skills.
To be eligible for this study, patients need to be between 18 and 65 years old and have had chronic low back pain for more than three months. They also need to be candidates for a specific rehabilitation program at one of the participating centers. There are some criteria that would exclude someone from participating, such as having certain other medical conditions or recent surgeries. If you join the study, you can expect to use the VR headset during your rehabilitation sessions, and researchers will evaluate how well it works for you and how you feel about using it. This trial will help gather important information that could lead to larger studies in the future, potentially improving treatment options for people with chronic low back pain.
Gender
ALL
Eligibility criteria
- Caregiver Inclusion Criteria:
- • Caregivers involved in RFR programs at participating centers and likely to use the VR tool during the program.
- • Consent of the caregiver to participate in the study.
- Patient Inclusion Criteria:
- • Aged between 18 and 65 years.
- • Diagnosed with chronic low back pain lasting more than three months, with secondary causes excluded.
- • Candidates for integration into an RFR program at one of the participating centers.
- • Affiliated with or beneficiaries of a social security scheme.
- • Provide informed consent to participate in the study
- Patient Exclusion Criteria:
- • Presence of any other condition incompatible with the RFR program.
- • Recent surgery or trauma (within the last month).
- • Contraindications for using the VR device, including unstable epilepsy, facial trauma within the last three months, hearing or visual impairments, or previous experiences of pain, dizziness, or nausea triggered by VR device use.
- • Visual impairments preventing the use of the VR device.
- • Pregnancy or breastfeeding.
- • Poor comprehension of the French language.
- • Incarceration by judicial or administrative decision.
- • Undergoing compulsory psychiatric treatment.
- • Subject to legal protection measures.
- • Incapable of providing informed consent.
About University Hospital, Angers
The University Hospital of Angers is a leading academic medical institution dedicated to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, the hospital leverages its multidisciplinary expertise and state-of-the-art facilities to investigate new therapeutic approaches and improve patient outcomes. Committed to excellence in patient care and medical education, the University Hospital of Angers collaborates with a network of researchers and healthcare professionals to facilitate groundbreaking studies across various medical fields, ensuring rigorous adherence to ethical standards and regulatory compliance. Through its clinical trial initiatives, the institution aims to contribute significantly to the advancement of medical knowledge and the development of effective treatments.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rennes, , France
Cholet, , France
Angers, , France
Laval, , France
Vannes, , France
Patients applied
Trial Officials
Romain CHAMPAGNE, MD
Principal Investigator
Hospital, Laval
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported